Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

NCT04666961 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT04666961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04666961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Phase 2
Overall status
Recruiting
Start date
February 3, 2021
Completion date
August 1, 2033
Enrollment
262 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ, extensive disease, mastectomy